CSC
LPCN icon

Caldwell Sutter Capital’s Lipocine LPCN Stock Holding History

Caldwell Sutter Capital’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.76K Hold
471
– – ﹤0.01% 681
2025
Q4 		$3.78K Hold
471
– – ﹤0.01% 663
2025
Q3 		$1.34K Hold
471
– – ﹤0.01% 776
2025
Q2 		$1.49K Hold
471
– – ﹤0.01% 747
2025
Q1 		$1.5K Hold
471
– – ﹤0.01% 760
2024
Q4 		$2.3K Hold
471
– – ﹤0.01% 732
2024
Q3 		$2.12K Hold
471
– – ﹤0.01% 749
2024
Q2 		$3.88K Hold
471
– – ﹤0.01% 664
2024
Q1 		$2.45K Hold
471
– – ﹤0.01% 730
2023
Q4 		$1.31K Hold
471
– – ﹤0.01% 801
2023
Q3 		$1.4K Hold
471
– – ﹤0.01% 767
2023
Q2 		$2.37K Hold
471
– – ﹤0.01% 715
2023
Q1 		$2.54K Buy
+471
New +$3.64K ﹤0.01% 477

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Caldwell Sutter Capital's LPCN Position: Q1 2026 in Review

Caldwell Sutter Capital held its Lipocine (LPCN) position steady in Q1 2026 at 471 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #681.

Caldwell Sutter Capital first reported a position in LPCN in Q1 2023 and has held it in 13 quarters since. The position peaked at $3.88K in Q2 2024. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Caldwell Sutter Capital held 471 shares of Lipocine worth $3.76K as of Q1 2026.
  • Caldwell Sutter Capital left its Lipocine share count unchanged in Q1 2026.
  • Lipocine made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q1 2026, its #681 holding.
  • Caldwell Sutter Capital first reported a position in Lipocine in Q1 2023 and has held it in 13 quarters since.
  • Caldwell Sutter Capital's Lipocine position peaked at $3.88K in Q2 2024.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.